Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthew Gagne

Showing results (11-20 of 55) with videos related to

Pageof 6
Sort By:
Nature Microbiology|August 17, 2021
SARS-CoV-2 variant prediction and antiviral drug design are enabled by RBD in vitro evolutionJiří Zahradník, Shir Marciano, Maya Shemesh, et al.
Biorxiv : the Preprint Server for Biology|April 20, 2022
Genome wide screen of RNAi molecules against SARS-CoV-2 creates a broadly potent prophylaxisOhad Yogev, Omer Weissbrod, Giorgia Battistoni, et al.
Cell Reports|January 31, 2024
Systems immunology of transcriptional responses to viral infection identifies conserved antiviral pathways across macaques and humansKalani Ratnasiri, Hong Zheng, Jiaying Toh, et al.
Frontiers in Veterinary Science|July 24, 2023
Investigation of the impact of clonal hematopoiesis on severity and pathophysiology of COVID-19 in rhesus macaquesTae-Hoon Shin, Yifan Zhou, Byung-Chul Lee, et al.
Communications Biology|March 17, 2023
From a genome-wide screen of RNAi molecules against SARS-CoV-2 to a validated broad-spectrum and potent prophylaxisOhad Yogev, Omer Weissbrod, Giorgia Battistoni, et al.
Biorxiv : the Preprint Server for Biology|February 15, 2023
Investigation of the Impact of Clonal Hematopoiesis on Severity and Pathophysiology of COVID-19 in Rhesus MacaquesTae-Hoon Shin, Yifan Zhou, Byung-Chul Lee, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 17, 2022
Rapid Detection and Characterization of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Omicron Variant in a Returning TravelerMary Elizabeth Sexton, Jesse J Waggoner, Ludy R Carmola, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology|September 19, 2019
Utility of In Vitro Bioactivity as a Lower Bound Estimate of In Vivo Adverse Effect Levels and in Risk-Based PrioritizationKatie Paul Friedman, Matthew Gagne, Lit-Hsin Loo, et al.
NPJ Vaccines|January 20, 2024
Three immunizations with Novavax's protein vaccines increase antibody breadth and provide durable protection from SARS-CoV-2Klara Lenart, Rodrigo Arcoverde Cerveira, Fredrika Hellgren, et al.
Biorxiv : the Preprint Server for Biology|May 20, 2021
Infection and vaccine-induced neutralizing antibody responses to the SARS-CoV-2 B.1.617.1 variantVenkata-Viswanadh Edara, Lilin Lai, Malaya K Sahoo, et al.
Pageof 6

Showing results (11-20 of 55) with videos related to

Sort By:
Pageof 6
Nature Microbiology|August 17, 2021
SARS-CoV-2 variant prediction and antiviral drug design are enabled by RBD in vitro evolutionJiří Zahradník, Shir Marciano, Maya Shemesh, et al.
Biorxiv : the Preprint Server for Biology|April 20, 2022
Genome wide screen of RNAi molecules against SARS-CoV-2 creates a broadly potent prophylaxisOhad Yogev, Omer Weissbrod, Giorgia Battistoni, et al.
Cell Reports|January 31, 2024
Systems immunology of transcriptional responses to viral infection identifies conserved antiviral pathways across macaques and humansKalani Ratnasiri, Hong Zheng, Jiaying Toh, et al.
Frontiers in Veterinary Science|July 24, 2023
Investigation of the impact of clonal hematopoiesis on severity and pathophysiology of COVID-19 in rhesus macaquesTae-Hoon Shin, Yifan Zhou, Byung-Chul Lee, et al.
Communications Biology|March 17, 2023
From a genome-wide screen of RNAi molecules against SARS-CoV-2 to a validated broad-spectrum and potent prophylaxisOhad Yogev, Omer Weissbrod, Giorgia Battistoni, et al.
Biorxiv : the Preprint Server for Biology|February 15, 2023
Investigation of the Impact of Clonal Hematopoiesis on Severity and Pathophysiology of COVID-19 in Rhesus MacaquesTae-Hoon Shin, Yifan Zhou, Byung-Chul Lee, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 17, 2022
Rapid Detection and Characterization of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Omicron Variant in a Returning TravelerMary Elizabeth Sexton, Jesse J Waggoner, Ludy R Carmola, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology|September 19, 2019
Utility of In Vitro Bioactivity as a Lower Bound Estimate of In Vivo Adverse Effect Levels and in Risk-Based PrioritizationKatie Paul Friedman, Matthew Gagne, Lit-Hsin Loo, et al.
NPJ Vaccines|January 20, 2024
Three immunizations with Novavax's protein vaccines increase antibody breadth and provide durable protection from SARS-CoV-2Klara Lenart, Rodrigo Arcoverde Cerveira, Fredrika Hellgren, et al.
Biorxiv : the Preprint Server for Biology|May 20, 2021
Infection and vaccine-induced neutralizing antibody responses to the SARS-CoV-2 B.1.617.1 variantVenkata-Viswanadh Edara, Lilin Lai, Malaya K Sahoo, et al.
Pageof 6